Concepedia

Publication | Open Access

Combination of Atezolizumab and Tazemetostat in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results From a Phase Ib Study

DOIFull Paper Access

44

Citations

23

References

2021

Year

Maria Lia Palomba, Guillaume Cartron, Leslie Popplewell, Vincent Ribrag, Jason R. Westin, Ling‐Yuh Huw, Shefali Agarwal, Mahesh Shivhare, Wan‐Jen Hong, Aparna Raval,
Clinical Lymphoma Myeloma & Leukemia

Abstract

The combination of atezolizumab and tazemetostat was determined to be safe and tolerable. However, anti-tumor activity of the combination was modest.

References

YearCitations

Page 1